{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:56:44Z","timestamp":1777939004384,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03273-y","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:40:42Z","timestamp":1774618842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thymoquinone decreases cell proliferation and immune evasion of breast cancer cells by reducing CD55 and CD114 levels"],"prefix":"10.1007","volume":"43","author":[{"given":"Nabiha","family":"Bashir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehreen","family":"Ishfaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeeda","family":"Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemal H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramla","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"3273_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/jclinpath-2012-201085","volume":"66","author":"N Pathmanathan","year":"2013","unstructured":"Pathmanathan N, Balleine RL. Ki67 and proliferation in breast cancer. J Clin Pathol. 2013;66:512\u20136.","journal-title":"J Clin Pathol"},{"key":"3273_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2015.02.006","volume":"35","author":"MA Feitelson","year":"2016","unstructured":"Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, et al. Sustained proliferation in cancer: therapeutic targets. Semin Cancer Biol. 2016;35:25\u201354.","journal-title":"Semin Cancer Biol"},{"key":"3273_CR3","doi-asserted-by":"crossref","unstructured":"Wang Z. Regulation of cell cycle progression by growth factor-induced cell signaling. Cells. 2021;10(12):3327.","DOI":"10.3390\/cells10123327"},{"key":"3273_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12071971","volume":"12","author":"AJ Brooks","year":"2020","unstructured":"Brooks AJ, Putoczki T. Jak-stat signalling pathway in cancer. Cancers (Basel). 2020;12:1\u20133.","journal-title":"Cancers (Basel)"},{"key":"3273_CR5","doi-asserted-by":"crossref","unstructured":"Guo Y, Pan W, Liu S, Shen Z, Xu Y, Hu L. ERK\/MAPK signalling pathway and tumorigenesis (Review). Exp Ther Med. 2020;19(3):1997\u20132007.","DOI":"10.3892\/etm.2020.8454"},{"key":"3273_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:1\u201330.","journal-title":"Front Immunol"},{"key":"3273_CR7","first-page":"61","volume":"9","author":"JM Thurman","year":"2020","unstructured":"Thurman JM, Laskowski J, Nemenoff RA, Complement. Cancer\u2014A Dysfunctional Relationship? Antibodies. 2020;9:61.","journal-title":"Cancer\u2014A Dysfunctional Relationship? Antibodies"},{"key":"3273_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","volume":"190","author":"CB Xie","year":"2020","unstructured":"Xie CB, Jane-Wit D, Pober JS. Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets. Am J Pathol. 2020;190:1138\u201350. https:\/\/doi.org\/10.1016\/j.ajpath.2020.02.006","journal-title":"Am J Pathol"},{"key":"3273_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2018.18.e11","volume":"18","author":"SH Dho","year":"2018","unstructured":"Dho SH, Lim JC, Kim LK. Beyond the role of CD55 as a complement component. Immune Netw. 2018;18:1\u201313.","journal-title":"Immune Netw"},{"key":"3273_CR10","doi-asserted-by":"crossref","unstructured":"Geller A, Yan J. The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy. Front Immunol. 2019;10:1\u201313.","DOI":"10.3389\/fimmu.2019.01074"},{"key":"3273_CR11","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-07-1844","volume":"14","author":"Jichiro Ikeda","year":"2008","unstructured":"Ikeda Jichiro, Morii E, Liu Y, Qiu Y, Nakamichi N, Jokoji R, et al. Prognostic significance of CD55 expression in breast cancer. Clin Cancer Res. 2008;14:4780\u20136.","journal-title":"Clin Cancer Res"},{"key":"3273_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5858\/arpa.2013-0064-OA","volume":"138","author":"Y Shang","year":"2014","unstructured":"Shang Y, Chai N, Gu Y, Ding L, Yang Y, Zhou J, et al. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med. 2014;138:910\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"3273_CR13","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.2147\/OTT.S195182","volume":"12","author":"X Yin","year":"2019","unstructured":"Yin X, Shen C, Yin Y, Cai Z, Wang J, Zhao Z, et al. Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors. Onco Targets Ther. 2019;12:4703\u201312.","journal-title":"Onco Targets Ther"},{"key":"3273_CR14","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.18632\/oncotarget.14053","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Zhang Z, Cao L, Lin J, Yang Z, Zhang X. A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer. Oncotarget. 2017;8:6216\u201321.","journal-title":"Oncotarget"},{"key":"3273_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers11111820","volume":"11","author":"G Giannone","year":"2019","unstructured":"Giannone G, Attademo L, Scotto G, Genta S, Ghisoni E, Tuninetti V, et al. Endometrial cancer stem cells: Role, characterization and therapeutic implications. Cancers (Basel). 2019;11:1\u201318.","journal-title":"Cancers (Basel)"},{"key":"3273_CR16","doi-asserted-by":"crossref","unstructured":"Hu X, li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. Springer US; 2021. p. 6.","DOI":"10.1038\/s41392-021-00791-1"},{"key":"3273_CR17","first-page":"365","volume":"113","author":"SJ Thomas","year":"2015","unstructured":"Thomas SJ, Snowden JA, Zeidler MP, Danson SJ. The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer Nat Publishing Group. 2015;113:365\u201371.","journal-title":"Br J Cancer Nat Publishing Group"},{"key":"3273_CR18","doi-asserted-by":"crossref","unstructured":"Lo U, Chen Y, Cen J, Deng S, Luo J, Zhau H et al. The driver role of JAK-STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy\u2010 and castration\u2010resistant prostate cancer. Clin Transl Med. 2022;12(8):e978.","DOI":"10.1002\/ctm2.978"},{"key":"3273_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.hoc.2012.10.002","volume":"27","author":"IP Touw","year":"2013","unstructured":"Touw IP, Palande K, Beekman R. Granulocyte Colony-Stimulating Factor Receptor Signaling. Implications for G-CSF Responses and Leukemic Progression in Severe Congenital Neutropenia. Hematol Oncol Clin North Am. 2013;27:61\u201373. https:\/\/doi.org\/10.1016\/j.hoc.2012.10.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"3273_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jcb.25656","volume":"118","author":"PE Zage","year":"2017","unstructured":"Zage PE, Whittle SB, Shohet JM. CD114: A new member of the neural Crest-Derived cancer stem cell marker family. J Cell Biochem. 2017;118:221\u201331.","journal-title":"J Cell Biochem"},{"key":"3273_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.seminoncol.2012.05.011","volume":"39","author":"J Ji","year":"2012","unstructured":"Ji J, Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol. 2012;39:461\u201372.","journal-title":"Semin Oncol"},{"key":"3273_CR22","doi-asserted-by":"crossref","unstructured":"Kaleli S, Deveci A, Gamze O, Eskiler G, Furkan K. Genistein enhances TLR3 \u2013 mediated apoptosis and immune signaling in breast cancer cells. Springer US; 2025.","DOI":"10.1007\/s12032-025-02856-5"},{"key":"3273_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.apjtm.2017.03.026","volume":"10","author":"OH Alobaedi","year":"2017","unstructured":"Alobaedi OH, Talib WH, Basheti IA. Antitumor effect of thymoquinone combined with resveratrol on mice transplanted with breast cancer. Asian Pac J Trop Med. 2017;10:400\u20138. https:\/\/doi.org\/10.1016\/j.apjtm.2017.03.026","journal-title":"Asian Pac J Trop Med"},{"key":"3273_CR24","unstructured":"Kamisetti RR, Thymoquinone. A promising agent in the prevention of breast cancer international. J Res in. 2024;13:325\u201331."},{"key":"3273_CR25","doi-asserted-by":"crossref","unstructured":"Zenkov RG, Kirsanov KI, Ogloblina AM, Vlasova OA, Naberezhnov DS, Karpechenko NY et al. Effects of G-Quadruplex-Binding plant secondary metabolites on c-MYC expression. Int J Mol Sci. 2022;23(16):9209.","DOI":"10.3390\/ijms23169209"},{"key":"3273_CR26","unstructured":"Riss TL, Moravec RA, Niles AL, Benink HA, Worzella TJ, Minor L. Cell Viability Assays. 2016;1\u201325. https:\/\/pubmed.ncbi.nlm.nih.gov\/23805433\/."},{"key":"3273_CR27","doi-asserted-by":"publisher","unstructured":"Cheng Y, Tang Q, Li Y, Zhang Y, Zhao C, Yan J et al. Folding\/unfolding kinetics of G-quadruplexes upstream of the P1 promoter of the human BCL-2 oncogene. J Biol Chem [Internet]. \u00c2\u00a9 THE AUTHORS. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.; 2019;294:5890\u20135. Available from: https:\/\/doi.org\/10.1074\/jbc.RA119.007516","DOI":"10.1074\/jbc.RA119.007516"},{"key":"3273_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.trechm.2019.07.002","volume":"2","author":"J Spiegel","year":"2020","unstructured":"Spiegel J, Adhikari S, Balasubramanian S. Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. Trends Chem. 2020;2:123\u201336. https:\/\/doi.org\/10.1016\/j.trechm.2019.07.002","journal-title":"Trends Chem"},{"key":"3273_CR29","doi-asserted-by":"crossref","unstructured":"Kikin O, D\u2019Antonio L, Bagga PS. QGRS mapper: A web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. 2006;1:34.","DOI":"10.1093\/nar\/gkl253"},{"key":"3273_CR30","doi-asserted-by":"crossref","unstructured":"Lopez C. RNA Extraction using Trizol. 2024;19\u201322.","DOI":"10.17504\/protocols.io.x54v922pml3e\/v1"},{"key":"3273_CR31","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u2206\u2206CT method. Methods. 2001;25(4):402\u20138.","DOI":"10.1006\/meth.2001.1262"},{"key":"3273_CR32","doi-asserted-by":"crossref","unstructured":"Sule R, Rivera G, Gomes AV. Western blotting (immunoblotting): history. 2023;6205.","DOI":"10.17504\/protocols.io.b5i4q4gw"},{"key":"3273_CR33","doi-asserted-by":"crossref","unstructured":"Dusell CD, Umetani M, Shaul PW, Mangelsdorf DJ, Mcdonnell DP. 27-Hydroxycholesterol is an endogenous selective Estrogen receptor modulator. Mol Endocrinol. 2015;22:65\u201377.","DOI":"10.1210\/me.2007-0383"},{"key":"3273_CR34","doi-asserted-by":"crossref","unstructured":"Hashemi M, Hesaraki M, Ramezankhani R, Yaghoubi SM, Shokouhian B, Piryaei A et al. Overexpression of KDM6A in Hepatoma Cells Induces Hepatocytic Differentiation and Attenuates Proliferation Rate, Colony Formation, and Migration Capacities. 2025;2025.","DOI":"10.1155\/bmri\/5551687"},{"key":"3273_CR35","doi-asserted-by":"crossref","unstructured":"Khan MA, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget. 2017;8(31):51907\u201319.","DOI":"10.18632\/oncotarget.17206"},{"key":"3273_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-8-6","volume":"8","author":"Y Welte","year":"2010","unstructured":"Welte Y, Adjaye J, Lehrach HR, Regenbrecht CRA. Cancer stem cells in solid tumors: elusive or illusive? Cell Commun Signal. 2010;8:1\u201310.","journal-title":"Cell Commun Signal"},{"key":"3273_CR37","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.2353\/ajpath.2010.091064","volume":"176","author":"S Sell","year":"2010","unstructured":"Sell S. On the stem cell origin of cancer. Am J Pathol. 2010;176:2584\u201394.","journal-title":"Am J Pathol"},{"key":"3273_CR38","first-page":"738","volume":"25","author":"F Badar","year":"2015","unstructured":"Badar F, Mahmood S, Faraz R, Yousaf A, ul Quader A, Asif H, et al. Epidemiology of breast cancer at the Shaukat Khanum memorial cancer hospital and research center, Lahore, Pakistan. J Coll Physicians Surg Pakistan. 2015;25:738\u201342.","journal-title":"J Coll Physicians Surg Pakistan"},{"key":"3273_CR39","first-page":"1087","volume":"2","author":"M Baig","year":"2019","unstructured":"Baig M, Sohail I, Altaf HN, Altaf OS. Factors influencing delayed presentation of breast cancer at a tertiary care hospital in Pakistan. Cancer Rep. 2019;2:1087\u201396.","journal-title":"Cancer Rep"},{"key":"3273_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.26719\/emhj.20.051","volume":"27","author":"I Majeed","year":"2021","unstructured":"Majeed I, Ammanuallah R, Anwar AW, Rafique HM, Imran F. Diagnostic and treatment delays in breast cancer in association with multiple factors in Pakistan. East Mediterr Heal J. 2021;27:23\u201332.","journal-title":"East Mediterr Heal J"},{"key":"3273_CR41","doi-asserted-by":"publisher","first-page":"563","DOI":"10.7314\/APJCP.2016.17.2.563","volume":"17","author":"M Mansha","year":"2016","unstructured":"Mansha M, Saleem M, Wasim M, Tariq M. Prevalence of known risk factors in women diagnosed with breast cancer at INMOL hospital, Lahore, Punjab. Asian Pac J Cancer Prev. 2016;17:563\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3273_CR42","first-page":"1","volume":"19","author":"S Zaheer","year":"2019","unstructured":"Zaheer S, Shah N, Maqbool SA, Soomro NM. Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, pakistan: 2004\u20132025. BMC Public Health BMC Public Health. 2019;19:1\u20139.","journal-title":"BMC Public Health BMC Public Health"},{"key":"3273_CR43","first-page":"18","volume":"27","author":"F Lateef","year":"2017","unstructured":"Lateef F, Jamal S, Nasir S, Jamil Z. Invasive ductal carcinoma: correlation of immunophenotypic features with age. J Coll Physicians Surg Pakistan. 2017;27:18\u201322.","journal-title":"J Coll Physicians Surg Pakistan"},{"key":"3273_CR44","first-page":"976","volume":"69","author":"SS Malik","year":"2019","unstructured":"Malik SS, Baig M, Bilal Khan M, Masood N. Survival analysis of breast cancer patients with different treatments: A multicentric clinicopathological study. J Pak Med Assoc. 2019;69:976\u201380.","journal-title":"J Pak Med Assoc"},{"key":"3273_CR45","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/sj.bjc.6602334","volume":"92","author":"L Bj\u00f8rge","year":"2005","unstructured":"Bj\u00f8rge L, Hakulinen J, Vintermyr OK, Jarva H, Jensen TS, Iversen OE, et al. Ascitic complement system in ovarian cancer. Br J Cancer. 2005;92:895\u2013905.","journal-title":"Br J Cancer"},{"key":"3273_CR46","doi-asserted-by":"publisher","first-page":"112616","DOI":"10.1016\/j.biopha.2022.112616","volume":"147","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zhou H, Wang K, Wang X, Wang M, Zhao W, et al. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development. Biomed Pharmacother. 2022;147:112616. https:\/\/doi.org\/10.1016\/j.biopha.2022.112616","journal-title":"Biomed Pharmacother"},{"key":"3273_CR47","doi-asserted-by":"crossref","unstructured":"Saygin C, Wiechert A, Rao VS, Alluri R, Connor E, Thiagarajan PS et al. CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors. J Exp Med. 2017;214(9):2715\u201332.","DOI":"10.1084\/jem.20170438"},{"key":"3273_CR48","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.urology.2007.02.035","volume":"69","author":"A Chakraborty","year":"2007","unstructured":"Chakraborty A, Guha S. Granulocyte Colony-Stimulating factor\/Granulocyte Colony-Stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. Urology. 2007;69:1210\u20135.","journal-title":"Urology"},{"key":"3273_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0923-1811(00)00131-6","volume":"25","author":"K Hirai","year":"2001","unstructured":"Hirai K, Kumakiri M, Fujieda S, Sunaga H, Lao LM, Imamura Y, et al. Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors. J Dermatol Sci. 2001;25:179\u201388.","journal-title":"J Dermatol Sci"},{"key":"3273_CR50","doi-asserted-by":"crossref","unstructured":"Salem AA, El Haty IA, Abdou IM, Mu Y. Interaction of human telomeric G-quadruplex DNA with thymoquinone: A possible mechanism for thymoquinone anticancer effect. Biochim Biophys Acta - Gen Subj; 2015.","DOI":"10.1016\/j.bbagen.2014.10.018"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03273-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03273-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03273-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:59:47Z","timestamp":1777697987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03273-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3273"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03273-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval and consent to participate: Ethical approval for the study was obtained from the Department of Biosciences Ethical Review Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The signed consent was obtained from the patient and included before sample collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent was obtained from the patients to publish the data at the time of sample collection.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"179"}}